Hetarylfuroxans: cytotoxic effect and induction of apoptosis in chronic myeloid leukemia K562 cells

被引：8

作者：

Pukhov, S. A. ^{[1
]}

Anikina, L. A. ^{[1
]}

Larin, A. A. ^{[2
]}

Fershtat, L. L. ^{[2
]}

Kulikov, A. S. ^{[2
]}

Makhova, N. N. ^{[2
]}

机构：

[1] Russian Acad Sci, Inst Physiol Act Cpds, 1 Severnyi Proezd, Chernogolovka 142432, Moscow Region, Russia

[2] Russian Acad Sci, ND Zelinsky Inst Organ Chem, 47 Leninsky Prosp, Moscow 119991, Russia

来源：

RUSSIAN CHEMICAL BULLETIN | 2019年 / 68卷 / 01期

基金：

俄罗斯基础研究基金会;

关键词：

cytotoxicity; chronic myeloid leukemia K562; hetarylfuroxans; apoptosis; caspase-3; caspase-7; ANTIAGGREGANT ACTIVITY; TYROSINE KINASE; INHIBITORS; FUROXANS; SYSTEMS; EVENTS; DESIGN;

D O I：

10.1007/s11172-019-2431-5

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Hetarylfuroxans (4-(2-methylpyridin-5-yloxy)-3-phenylfuroxan (1), bis(1,2,4-oxadiazol-3-yl)furoxan (2), and 4-amino-3-(indenotriazin-3-yl)furoxan (3)) exhibit in vitro cytotoxic activity against chronic myeloid leukemia K562 cells. All studied furoxans induce apoptosis in K562 cells. The experiments with activation of caspases-3 and -7 showed that furoxan 3 possessed the highest apoptosis-inducing capacity. The studied hetarylfuroxans were found to be the promising drug candidates for the treatment of chronic myeloid leukemia K562.

引用

页码：158 / 162

页数：5

共 31 条

[1] Death receptors: Signaling and modulation [J].

Ashkenazi, A ;

Dixit, VM .

SCIENCE, 1998, 281 (5381) :1305-1308

[2] Imatinib derivatives as inhibitors of K562 cells in chronic myeloid leukemia [J].

Azevedo, Liviane D. ;

Bastos, Monica M. ;

Vasconcelos, Flavia C. ;

Hoelz, Lucas V. B. ;

Junior, Floriano P. S. ;

Dantas, Rafael F. ;

de Almeida, Ana C. M. ;

de Oliveira, Andressa Paula ;

Gomes, Larissa C. ;

Maia, Raquel C. ;

Boechat, Nubia .

MEDICINAL CHEMISTRY RESEARCH, 2017, 26 (11) :2929-2941

[3] Pharmacological properties of furoxans and benzofuroxans: Recent developments [J].

Cerecetto, H ;

Porcal, W .

MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (01) :57-71

[4]

Cheng R., 2010, NITRIC OXIDE CANC PR

[5] Design, Synthesis, and Pharmacological Evaluation of Novel Hybrid Compounds to Treat Sickle Cell Disease Symptoms. Part II: Furoxan Derivatives [J].

Dos Santos, Jean Leandro ;

Lanaro, Carolina ;

Chelucci, Rafael Consolin ;

Gambero, Sheley ;

Bosquesi, Priscila Longhin ;

Reis, Juliana Santana ;

Lima, Lidia Moreira ;

Cerecetto, Hugo ;

Gonzalez, Mercedes ;

Costa, Fernando Ferreira ;

Chung, Man Chin .

JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (17) :7583-7592

[6] Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome. [J].

Druker, BJ ;

Sawyers, CL ;

Kantarjian, H ;

Resta, DJ ;

Reese, SF ;

Ford, JM ;

Capdeville, R ;

Talpaz, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1038-1042

[7] Molecular Hybridization Tools in the Development of Furoxan-Based NO-Donor Prodrugs [J].

Fershtat, Leonid L. ;

Makhova, Nina N. .

CHEMMEDCHEM, 2017, 12 (09) :622-638

[8] Advances in the synthesis of non-annelated polynuclear heterocyclic systems comprising the 1,2,5-oxadiazole ring [J].

Fershtat, Leonid L. ;

Makhova, Nina N. .

RUSSIAN CHEMICAL REVIEWS, 2016, 85 (10) :1097-1145

[9] Design of hybrid heterocyclic systems with a furoxanylpyridine core via tandem hetero-Diels-Alder/retro-Diels-Alder reactions of (1,2,4-triazin-3-yl)furoxans [J].

Fershtat, Leonid L. ;

Larin, Alexander A. ;

Epishina, Margarita A. ;

Ovchinnikov, Igor V. ;

Kulikov, Alexander S. ;

Ananyev, Ivan V. ;

Makhova, Nina N. .

RSC ADVANCES, 2016, 6 (37) :31526-31539

[10] Efficient assembly of mono- and bis(1,2,4-oxadiazol-3-yl)furoxan scaffolds via tandem reactions of furoxanylamidoximes [J].

Fershtat, Leonid L. ;

Ananyev, Ivan V. ;

Makhova, Nina N. .

RSC ADVANCES, 2015, 5 (58) :47248-47260

← 1 2 3 4 →